3d Cell Culture Market – Global Industry Analysis and Forecast To 2025

3D-cell culture Market

The Latest  research study titled, “3D Cell Culture Market by Technology, Application, and End User – Global Industry Analysis and Forecast to 2025” published by Crystal Market Research, states that the 3D cell culture market is projected to be around $1.8 billion by 2025.

3D cell culture is synthetically-created environment in which cells are allowed to grow in all three dimensions unlike 2D cells. 3D cell culture is one of the fastest growing segments in life sciences industry, due to its wide range of applications in cancer research, regenerative medicines, and in-vitro cell assays. This can be attributed to the fact that these cell culture systems have replaced animal models in certain clinical experiments as these cells closely resemble cells in vivo. These 3D cells form natural cell-to-cell interactions as well as facilitate exchange of ions and electrical signals resembling those occurring in vivo.

3D cell cultures are increasingly replacing 2D cell culture as they help to overcome problems associated with the use of 2D cell cultures. However, 3D cell culture is emerging field providing tremendous opportunities for the market growth. High demand for organ transplantation and tissue regeneration, and increasing need of regenerative medicines for diseases such as cancer and diabetes will play vital role in the market growth. Scaffold-based cell cultures have unique property of adjusting biochemical and mechanical property due to which these are widely used in regenerative medicine and 3D printing. Micro patterned surfaces are expected to witness highest growth during the forecast period owing to its high drug reactivity and enzyme activity. Stem cell-based culture systems are expected to witness highest growth in the forecast period, due to their application in tissue and organ regeneration. This leads to large scale adoption of 3D cell culture systems by biotech & pharmaceutical companies, hospitals, and diagnostic centers, which further contributes to the market growth. Besides, rise in prevalence of cancer will increase need for cancer research and development of regenerative medicines that will drive the market during forecast period.

North America accounted for almost two-fifth of the global share of 3D cell cultures market in 2016. This is primarily attributed to a number of factors such as large number of research laboratories, collaboration of biotech and pharma companies for developing advance technology, and various government initiatives to support research and development of 3D cell culture systems in North America. Asia-Pacific is projected to be the fastest-growing region during the forecast period, due to increase in stem cell research in countries such as India, China, and Japan. Many key players are focusing on Asia-Pacific regions due to low cost of operations in this region. Companies are focusing on developing technologies tailored for particular research activity. For instance, in 2014, Japan based company, Reprocell acquired Human Tissue supplier Bioserve for integrating pluripotent stem cell technology and 3D cell culture technology to enhance efficiency of drug testing and cancer research.

Get PDF copy of an Exclusive Report @ https://www.crystalmarketresearch.com/report-sample/HC0516

Top Players in Market:

Some of the major companies include Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Nano 3D Biosciences, Promocell GmbH, Corning Inc., Biomatrix, Lonza, VWR International, LLC, Tecan Trading AG., 3D Biotek LLC., Global Cell Solutions, Inc., and InSphero AG.

Designed by CyFocus.com
Powered by CyFocus.net